This paper is in the following e-collection/theme issue:

Systematic Review Protocols (335) Drug Repurposing and Off-Label Use (28)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38658, first published .
The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

Authors of this article:

João Estarreja1 Author Orcid Image ;   Priscila Mendes1 Author Orcid Image ;   Carina Silva1, 2 Author Orcid Image ;   Pedro Camacho1 Author Orcid Image ;   Vanessa Mateus1, 3 Author Orcid Image
Article Authors Cited by (8) Tweetations (2) Metrics

Journals

  1. Santorsola M, Capuozzo M, Nasti G, Sabbatino F, Di Mauro A, Di Mauro G, Vanni G, Maiolino P, Correra M, Granata V, Gualillo O, Berretta M, Ottaiano A. Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. Cancers 2024;16(2):350 View
  2. Estarreja J, Mendes P, Silva C, Camacho P, Mateus V. Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. Pharmaceuticals 2024;17(8):1000 View
  3. Fellner Z, Majtánová N, Kolář P, Krišková P, Keri P. Treatment Regimens of Neovascular Form of Age-Related Macular Degeneration. A Review. Czech and Slovak Ophthalmology 2024;80(6):287 View
  4. Studnička J, Němčanský J, Vysloužilová D, Ernest J, Veith M, Němec P. Retinal Vein Occlusion Guidelines. Czech and Slovak Ophthalmology 2024;80(6):296 View
  5. Wojciechowski P, Wdowiak M, Panek M, Lunk I, Carrasco J, Zhang X, Wu O, Korobelnik J, Lanzetta P. Efficacy, Safety, and Injection Frequency with Novel Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: A Comparison with Existing Anti-VEGF Regimens Using a Bayesian Network Meta-Analysis. Ophthalmology and Therapy 2025;14(4):733 View
  6. Li H, Huang X. Advances in the molecular signaling mechanisms of VEGF/VEGFR2 in fundus neovascularization disease (Review). Experimental and Therapeutic Medicine 2025;30(1):1 View
  7. Chong D, Yue S, Raynor J, Murray I, Chuchta T, Markle J, Shaia J, Singh R, Talcott K. Estimated Five-year Risk of Systemic Cardiovascular Events With Anti-VEGF Injections in Neovascular Age-related Macular Degeneration. Ophthalmic Surgery, Lasers and Imaging Retina 2025;56(10):587 View

Books/Policy Documents

  1. Seber E, Yaylacı S. Cell Biology and Translational Medicine, Volume 27. View